scholarly article | Q13442814 |
P50 | author | Anavaj Sakuntabhai | Q17916848 |
Félix G Delgado | Q54377995 | ||
Claude Roth | Q59146351 | ||
Etienne Simon-Loriere | Q29460611 | ||
Jaime Eduardo Castellanos | Q39559697 | ||
P2093 | author name string | Consuelo Romero-Sánchez | |
Karina I Torres | |||
P2860 | cites work | Zika virus. I. Isolations and serological specificity | Q22240545 |
Zika Virus Outbreak on Yap Island, Federated States of Micronesia | Q22250881 | ||
Zika Virus Outbreak, Bahia, Brazil | Q22330702 | ||
First report of autochthonous transmission of Zika virus in Brazil | Q22330715 | ||
Co-infection with Zika and dengue viruses in 2 patients, New Caledonia, 2014 | Q22330724 | ||
Zika Virus, French Polynesia, South Pacific, 2013 | Q22330743 | ||
Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013 | Q22330748 | ||
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study | Q23012849 | ||
Association between Zika virus and microcephaly in French Polynesia, 2013–15: a retrospective study | Q24255260 | ||
Phylogeny of the genus Flavivirus | Q24471099 | ||
Zika Virus Disease in Colombia — Preliminary Report | Q24653922 | ||
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus | Q24737245 | ||
Structural basis of potent Zika–dengue virus antibody cross-neutralization | Q24740325 | ||
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus | Q25161212 | ||
Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus | Q26247258 | ||
Easy and inexpensive molecular detection of dengue, chikungunya and zika viruses in febrile patients | Q26252062 | ||
Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection | Q26252507 | ||
Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections | Q27469477 | ||
Differential Functional Avidity of Dengue Virus-Specific T-Cell Clones for Variant Peptides Representing Heterologous and Previously Encountered Serotypes | Q27481452 | ||
Microcephaly in north-east Brazil: a retrospective study on neonates born between 2012 and 2015 | Q27927987 | ||
Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins | Q28119724 | ||
Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice | Q28223043 | ||
Zika Virus Seroprevalence, French Polynesia, 2014–2015 | Q28310404 | ||
Dengue virus antibodies enhance Zika virus infection | Q28353949 | ||
Dengue: knowledge gaps, unmet needs, and research priorities | Q28729764 | ||
Analysis of the T Cell Response to Zika Virus and Identification of a Novel CD8+ T Cell Epitope in Immunocompetent Mice | Q28833083 | ||
Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells | Q28950660 | ||
Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection | Q29051494 | ||
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity | Q29196526 | ||
Adaptive Immune Responses to Zika Virus Are Important for Controlling Virus Infection and Preventing Infection in Brain and Testes | Q29365210 | ||
Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology | Q29994510 | ||
Zika virus evolution and spread in the Americas | Q30145571 | ||
Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes | Q30145601 | ||
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico | Q30145646 | ||
Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus | Q33850577 | ||
Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. | Q34165624 | ||
Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection. | Q34518791 | ||
The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes | Q34992520 | ||
Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera | Q35294150 | ||
Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity | Q35701686 | ||
Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification | Q36260214 | ||
NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets | Q36742441 | ||
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells | Q36895622 | ||
CD8(+) T Cell Immune Response in Immunocompetent Mice during Zika Virus Infection | Q38156594 | ||
Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors. | Q38156674 | ||
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques | Q38157106 | ||
T cell immunity to dengue virus and implications for vaccine design. | Q38631171 | ||
Prediction of promiscuous T-cell epitopes in the Zika virus polyprotein: An in silico approach | Q38820777 | ||
Measuring antibody neutralization of dengue virus (DENV) using a flow cytometry-based technique | Q39008705 | ||
Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies | Q39268319 | ||
From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein | Q40053057 | ||
Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: A first step towards vaccine development | Q40053684 | ||
A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood. | Q40099738 | ||
Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine | Q40527785 | ||
Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans | Q41924182 | ||
Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individuals | Q42187290 | ||
An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction | Q47548142 | ||
Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses | Q47549528 | ||
Sustained specific and cross-reactive T cell responses to Zika and Dengue viruses NS3 in West Africa | Q47555900 | ||
Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL. | Q47558388 | ||
Antibody-dependent enhancement of severe dengue disease in humans | Q47592202 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | virology | Q7215 |
infectious disease | Q18123741 | ||
Zika virus | Q202864 | ||
Zika virus infection | Q27043680 | ||
P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
P304 | page(s) | 480 | |
P577 | publication date | 2018-09-07 | |
P1433 | published in | Viruses | Q7935305 |
P1476 | title | Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans | |
P478 | volume | 10 |